awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30251738-CF4CB15A-6045-4A1F-B2F1-5997CA1B2F1F
Q30251738-CF4CB15A-6045-4A1F-B2F1-5997CA1B2F1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30251738-CF4CB15A-6045-4A1F-B2F1-5997CA1B2F1F
Translating neoadjuvant therapy into survival benefits: one size does not fit all.
P2860
Q30251738-CF4CB15A-6045-4A1F-B2F1-5997CA1B2F1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30251738-CF4CB15A-6045-4A1F-B2F1-5997CA1B2F1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
73343e46a64dcf79922f7c22fafbcdf0ef965016
P2860
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.